Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients

Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients at Risk for Respiratory Failure

The aim of our study is to determine whether a clinically relevant laboratory measurement (of seven specific immunologic biochemicals in the blood) can identify which bone marrow transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to devise a comprehensive and inclusive laboratory test that is effective at determining who is likely to go on to respiratory failure, in order to facilitate early medical intervention.

Inclusion Criteria:- Hematopoietic stem cell transplantation (HSCT) for any indication.

• Patients will range from age 0 to age 21. There is no gender restriction. We expect the male to female ratio to end up being about 50/50
• Ability to understand and the willingness to sign a written informed consent document.